Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by PoorOpinion


IMVIF

RE:RE:RE:RE:Analyst upgrades

GorgeousGeorge1 wrote: No, it's more a case of - with the information we...

November 22, 2018

IMVIF

Speculating on the biomarker

(just some fun, I'm sure there are lots of possible candidates, I'd...

November 22, 2018

IMVIF

RE:RE:FDA meeting timeline

TexasTea20 wrote: Just my opinion but I doubt an update on breakthough...

November 22, 2018

IMVIF

FDA meeting timeline

Thought people might want to get a handle on possible news flow timeline from...

November 21, 2018

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:A Timeline for the next 6-8 months

jfm1330 wrote: What would be a non conventionnal phase III? A 40 patients...

November 21, 2018

IMVIF

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:DPX-Survivac as Monotherapy For Recurring Ovarian Cancer

alphaseeking001 wrote: Yikes... hoping it won't take that long to get...

November 20, 2018

IMVIF

RE:RE:RE:RE:RE:RE:RE:RE:DPX-Survivac as Monotherapy For Recurring Ovarian Cancer

PoorOpinion wrote: TexasTea20 wrote: As much as I think it would help...

November 20, 2018

IMVIF

RE:RE:RE:RE:RE:RE:RE:DPX-Survivac as Monotherapy For Recurring Ovarian Cancer

TexasTea20 wrote: As much as I think it would help liquidity, valuation etc.....

November 20, 2018

IMVIF

RE:RE:RE:RE:RE:RE:RE:DPX-Survivac as Monotherapy For Recurring Ovarian Cancer

My immediate response on reading this was somewhat negative. It seemed like...

November 20, 2018

T.TH

Some (very) general reading ........

........... I thought was interesting. Enjoy! Really big winners compound...

November 16, 2018

T.VLE

RE:RE:RE:Holding off does pay off

Plunge? Its about the same price it was at the start of the year. An exciting...

November 12, 2018

ATBPF

RE:RE:Zacks update

I found his 3 reports.   Citagenix sales forecast Zacks from Mar...

November 12, 2018

ATBPF

RE:Zacks update

Thanks. Do you have a copy of his older report? My memory is for his forecast...

November 12, 2018

T.TH

RE:RE:RE:Some interesting UK HIV data

Wino115 wrote: One other fact about Europe is that something like half the...

November 9, 2018

T.TH

Some interesting UK HIV data

From this website (government national stats) https://www.gov.uk/government...

November 9, 2018

T.GUD

RE:RE:RE:RE:RE:Enterprise Value to Sales Valuation

Note of caution. The success rate may be 5% but this number would be for...

November 8, 2018

T.TH

Where can I find TH's market research?

I'm sure you remember the March 2017 investor conference when they...

November 7, 2018

T.VLE

RE:RE:What transpired after 2010?

PoorOpinion wrote: LeJames wrote: I did a little bit of research on the...

November 5, 2018

T.VLE

RE:What transpired after 2010?

LeJames wrote: I did a little bit of research on the history of oil and gas...

November 5, 2018

T.TH

RE:RE:RE:RE:RE:RE:Taimed up.

You're right about the confusion. I'm assuming the 'flatness'...

November 3, 2018